Opiant Pharmaceuticals, Inc.
OPNT · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $38 | $48 | $31 | $25 |
| Short-Term Investments | $15 | $0 | $0 | $0 |
| Receivables | $13 | $9 | $7 | $4 |
| Inventory | -$2,960 | -$1,935 | -$1,055 | $0 |
| Other Curr. Assets | $2,963 | $1,937 | $1,056 | $0 |
| Total Curr. Assets | $69 | $59 | $39 | $29 |
| Property Plant & Equip (Net) | $1 | $0 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $0 | $0 |
| Total NC Assets | $1 | $2 | $1 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $70 | $61 | $40 | $29 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $1 |
| Other Curr. Liab. | $3 | $3 | $3 | $7 |
| Total Curr. Liab. | $7 | $6 | $6 | $10 |
| LT Debt | $17 | $19 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $3 |
| Total NC Liab. | $17 | $19 | $0 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $24 | $25 | $6 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$62 | -$65 | -$63 | -$74 |
| AOCI | -$0 | -$0 | $0 | $0 |
| Other Equity | $109 | $100 | $97 | $91 |
| Total Equity | $47 | $35 | $34 | $17 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $70 | $61 | $40 | $29 |
| Net Debt | -$21 | -$29 | -$30 | -$25 |